Adbry clinical results
Approved for adults and children ages 12+ years. Click here for different pediatric dosing information.
The safety of Adbry® (tralokinumab-ldrm) was studied in 5 clinical trials. Find out what to know before starting Adbry, and the most common side effects to be aware of.
Before starting Adbry
Before using ADBRY, tell your healthcare provider about all your medical conditions, including if you:
What are the possible side effects of ADBRY?
ADBRY can cause serious side effects, including:
Most common side effects
The most common side effects of ADBRY include:
- eye and eyelid , including redness, swelling, and itching
- injection site reactions
- high count of a certain white blood cell (eosinophilia)